acquired
Stage
About
InSilixa developed a mass-deployable, high-performance medical diagnostics technology platform that rapidly identifies pathogens in clinical samples and detects genetic mutations causing antibiotic resistance.
Explore InSilixa's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.